|
1
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel non-coding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tripathi V, Ellis JD, Shen Z, Song DY, Pan
Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The
nuclear-retained non-coding RNA MALAT1 regulates alternative
splicing by modulating SR splicing factor phosphorylation. Mol
Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic non-coding RNAs: New links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kornienko AE, Guenzl PM, Barlow DP and
Pauler FM: Gene regulation by the act of long non-coding RNA
transcription. BMC Biol. 11:592013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu S, Jin C, Shen X, Fang D, Zhu J and Fu
G: MicroRNAs as potential novel therapeutic targets and tools for
regulating paracrine function of endothelial progenitor cells. Med
Sci Monit. 18:HY27–HY31. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wilusz JE, Sunwoo H and Spector DL: Long
non-coding RNAs: Functional surprises from the RNA world. Genes
Dev. 23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z,
Deng X, Chen H, Shen B, Peng C, et al: Amplification of long
non-coding RNA ZFAS1 promotes metastasis in hepatocellular
carcinoma. Cancer Res. 75:3181–3191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X,
Lin L, Yao H, Su F, Li D, et al: A cytoplasmic NF-kappaB
interacting long non-coding RNA blocks IkappaB phosphorylation and
suppresses breast cancer metastasis. Cancer Cell. 27:370–381. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schorderet P and Duboule D: Structural and
functional differences in the long non-coding RNA hotair in mouse
and human. PLoS Genet. 7:e10020712011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schmidt LH, Spieker T, Koschmieder S,
Schäffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D,
Marra A, et al: The long non-coding MALAT-1 RNA indicates a poor
prognosis in non-small cell lung cancer and induces migration and
tumor growth. J Thorac Oncol. 6:1984–1992. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fellenberg J, Bernd L, Delling G, Witte D
and Zahlten-Hinguranage A: Prognostic significance of
drug-regulated genes in high-grade osteosarcoma. Mod Pathol.
20:1085–1094. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu C, Yang M, Tian J, Wang X and Li Z:
MALAT-1: A long non-coding RNA and its important 3′ end functional
motif in colorectal cancer metastasis. Int J Oncol. 39:169–175.
2011.PubMed/NCBI
|
|
16
|
Lin R, Maeda S, Liu C, Karin M and
Edgington TS: A large non-coding RNA is a marker for murine
hepatocellular carcinomas and a spectrum of human carcinomas.
Oncogene. 26:851–858. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ding Y, Zhang C, Zhang J, Zhang N, Li T,
Fang J, Zhang Y, Zuo F, Tao Z, Tang S, et al: miR-145 inhibits
proliferation and migration of breast cancer cells by directly or
indirectly regulating TGF-β1 expression. Int J Oncol. 50:1701–1710.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zou C, Xu Q, Mao F, Li D, Bian C, Liu LZ,
Jiang Y, Chen X, Qi Y, Zhang X, et al: MiR-145 inhibits tumor
angiogenesis and growth by N-RAS and VEGF. Cell Cycle.
11:2137–2145. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yin Y, Yan ZP, Lu NN, Xu Q, He J, Qian X,
Yu J, Guan X, Jiang BH and Liu LZ: Downregulation of miR-145
associated with cancer progression and VEGF transcriptional
activation by targeting N-RAS and IRS1. Biochim Biophys Acta.
1829:239–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan L, Wu Q, Xing X, Wei Y and Shao Z:
MicroRNA-145 targets vascular endothelial growth factor and
inhibits invasion and metastasis of osteosarcoma cells. Acta
Biochim Biophys Sin. 44:407–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mohinta S, Wu H, Chaurasia P and Watabe K:
Wnt pathway and breast cancer. Front Biosci. 12:4020–4033. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Geng YJ, Xie SL, Li Q, Ma J and Wang GY:
Large intervening non-coding RNA HOTAIR is associated with
hepatocellular carcinoma progression. J Int Med Res. 39:2119–2128.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gutschner T, Baas M and Diederichs S:
Non-coding RNA gene silencing through genomic integration of RNA
destabilizing elements using zinc finger nucleases. Genome Res.
21:1944–1954. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudogene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo JH, Ren B, Keryanov S, Tseng GC, Rao
UNM, Monga SP, Strom S, Demetris AJ, Nalesnik M, Yu YP, et al:
Transcriptomic and genomic analysis of human hepatocellular
carcinomas and hepatoblastomas. Hepatology. 44:1012–1024. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Song Y, Liu F, Liu D, Miao H, Ren J,
Xu J, Ding L, Hu Y, Wang Z, et al: Long non-coding RNA MALAT1
promotes proliferation, angiogenesis, and immunosuppressive
properties of mesenchymal stem cells by inducing VEGF and IDO. J
Cell Biochem. 118:2780–2791. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shi D and Zhang Y, Lu R and Zhang Y: The
long non-coding RNA MALAT1 interacted with miR-218 modulates
choriocarcinoma growth by targeting Fbxw8. Biomed Pharmacother.
97:543–550. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Plate KH, Breier G, Weich HA and Risau W:
Vascular endothelial growth factor is a potential tumour
angiogenesis factor in human gliomas in vivo. Nature. 359:845–848.
1992. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vlahakis NE, Young BA, Atakilit A,
Hawkridge AE, Issaka RB, Boudreau N and Sheppard D: Integrin
alpha9beta1 directly binds to vascular endothelial growth factor
(VEGF)-A and contributes to VEGF-A-induced angiogenesis. J Biol
Chem. 282:15187–15196. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, Li
D, Lai L and Jiang BH: MiR-145 directly targets p70S6K1 in cancer
cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res.
40:761–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ebert MS and Sharp PA: Emerging roles for
natural MicroRNA sponges. Curr Biol. 20:R858–R861. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tay Y, Kats L, Salmena L, Weiss D, Tan SM,
Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, et al:
Coding-independent regulation of the tumor suppressor PTEN by
competing endogenous mRNAs. Cell. 147:344–357. 2011. View Article : Google Scholar : PubMed/NCBI
|
